Loading...
Dapsone
India Pharmaceutical Trade Intelligence
Who Supplies Dapsone to India from UNITED STATES
India's dapsone imports from UNITED STATES total $219.3K across 109 shipments from 11 foreign suppliers. AGRACE PHARMA leads with $182.3K in import value; the top 5 suppliers together control 96.1% of this origin. Leading Indian buyers include ENCUBE ETHICALS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for dapsone — a diversified sourcing base with multiple active suppliers from UNITED STATES.
Top foreign suppliers (UNITED STATES) — Ranked by import value
AGRACE PHARMA is the leading Dapsone supplier from UNITED STATES to India, with import value of $182.3K across 2 shipments. The top 5 suppliers — AGRACE PHARMA, ESPEE BIOPHARMA & FINECHEM LLC, REGIONAL PHARMACY, ESPEE BIOPHARMA AND FINECHEM LLC, ESPEE BIOPHARMA FINECHEM LLC — collectively account for 96.1% of total import value from this origin.
Top foreign suppliers (UNITED STATES)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AGRACE PHARMA | $182.3K | 2 | 83.1% |
| 2 | ESPEE BIOPHARMA & FINECHEM LLC | $12.5K | 3 | 5.7% |
| 3 | REGIONAL PHARMACY | $5.8K | 1 | 2.6% |
| 4 | ESPEE BIOPHARMA AND FINECHEM LLC | $5.3K | 1 | 2.4% |
| 5 | ESPEE BIOPHARMA FINECHEM LLC | $4.9K | 3 | 2.2% |
| 6 | NOVITIUM PHARMA LLC | $3.5K | 87 | 1.6% |
| 7 | AMNEAL PHARMACEUTICALS, LLC | $2.1K | 4 | 0.9% |
| 8 | AGRACE PHARM | $1.7K | 1 | 0.8% |
| 9 | NOSTRUM LABORATORIES, INC. | $734 | 4 | 0.3% |
| 10 | ESPEE BIOPHARMA & FINCHEM LLC | $458 | 1 | 0.2% |
| 11 | ANI PHARMACEUTICALS INC | $0 | 2 | 0.0% |
Showing top 11 of 11 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from UNITED STATES)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ENCUBE ETHICALS PRIVATE LIMITED | $178.2K | 2 | 81.2% |
| 2 | ALEMBIC PHARMACEUTICALS LIMITED | $13.0K | 2 | 5.9% |
| 3 | CADILA PHARMACEUTICALS LIMITED | $9.3K | 1 | 4.2% |
| 4 | TORRENT PHARMACEUTICALS LTD | $5.8K | 1 | 2.6% |
| 5 | NOVITIUM LABS PRIVATE LIMITED | $3.5K | 89 | 1.6% |
| 6 | AUROBINDO PHARMA LTD | $2.7K | 1 | 1.2% |
| 7 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $2.1K | 4 | 0.9% |
| 8 | J B CHEMICALS AND PHARMACEUTICALS LIMITED | $1.7K | 1 | 0.8% |
| 9 | CADILA HEALTHCARE LIMITED | $1.4K | 2 | 0.6% |
| 10 | ENEM NOSTRUM REMEDIES PRIVATE LIMITED | $734 | 4 | 0.3% |
| 11 | ZYDUS LIFESCIENCES LIMITED | $582 | 1 | 0.3% |
| 12 | CLIANTHA RESEARCH LIMITED | $458 | 1 | 0.2% |
Import Statistics
- Import Value
- $219.3K
- Shipments
- 109
- Foreign Suppliers
- 11
- Indian Buyers
- 12
- Avg. Shipment
- $2.0K
Other Dapsone Import Origins
Related Analysis
Frequently Asked Questions — Dapsone Imports from UNITED STATES
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Dapsone suppliers from UNITED STATES to India?
The top Dapsone suppliers from UNITED STATES to India include AGRACE PHARMA, ESPEE BIOPHARMA & FINECHEM LLC, REGIONAL PHARMACY. The leading supplier is AGRACE PHARMA with import value of $182.3K USD across 2 shipments. India imported Dapsone worth $219.3K USD from UNITED STATES in total across 109 shipments.
QHow much Dapsone does India import from UNITED STATES?
India imported Dapsone worth $219.3K USD from UNITED STATES across 109 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Dapsone from UNITED STATES?
The main Indian buyers of Dapsone sourced from UNITED STATES include ENCUBE ETHICALS PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, CADILA PHARMACEUTICALS LIMITED. The largest buyer is ENCUBE ETHICALS PRIVATE LIMITED with $178.2K in imports across 2 shipments.
QWhat is the total value of Dapsone imports from UNITED STATES to India?
The total value of Dapsone imports from UNITED STATES to India is $219.3K USD, across 109 shipments and 11 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: UNITED STATES to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Dapsone.
- 2.Supplier/Buyer Matching: 11 foreign suppliers from UNITED STATES and 12 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $219.3K aggregated from 109 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
109 Verified Shipments
11 suppliers, 12 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists